Application of Artificial Intelligence in Symptom Monitoring in Adult Cancer Survivorship: A Systematic Review
Einsatz von Künstlicher Intelligenz bei der Symptomüberwachung im Überleben nach Krebs im Erwachsenenalter: systematische Übersichtsarbeit
JCO Clinical Cancer Informatics · 2024-12 · (8)
DOI: 10.1200/cci.24.00119 ↗Auf einen Blick
Die systematische Übersichtsarbeit zeigt eine zunehmende Nutzung von KI zur Vorhersage und Überwachung von Krebssymptomen bei erwachsenen Krebsüberlebenden. Am häufigsten wurden Schmerz, Fatigue und Übelkeit untersucht.
Fragestellung
Welche Rolle spielt KI bei der Symptomüberwachung bei erwachsenen Krebsüberlebenden?
Methode
Systematische Übersichtsarbeit; Suche von Beginn bis November 2023 in 7 bibliografischen Datenbanken und 3 Studienregistern.
Ergebnisse
41 Studien wurden analysiert. Meist waren Kohortenstudien (80,5 %) und Querschnittsstudien (12,2 %); mittlere Stichprobengröße 617,14 (SD 1.401,37).
Schlussfolgerung der Autor:innen
KI wird eingesetzt, um die Symptomüberwachung in verschiedenen Krebskontexten zu verbessern.
Kernaussagen
- 41 Studien erfüllten die Review-Kriterien
- Am häufigsten: Machine Learning, danach NLP
- Schmerz war das am häufigsten untersuchte Symptom
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift JCO Clinical Cancer Informatics, 2024-12. Verfasst von Sanam Tabataba Vakili und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Science Centre, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Artificial Intelligence, Cancer Survivors, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
PURPOSE The adoption of artificial intelligence (AI) in health care may afford new avenues for personalized and patient-centered care. This systematic review explored the role of AI in symptom monitoring for adult cancer survivors. METHODS A comprehensive search was performed from inception to November 2023 in seven bibliographic databases and three clinical trial registries. This PROSPERO registered review (ID: CRD42023476027) assessed reports of empirical research studies of AI use in symptom monitoring (physical and psychological symptoms) across all cancer types in adults. RESULTS A total of 18,530 reports were identified, of which 41 met review criteria and were analyzed. Included studies were predominantly published between 2021 and 2023, originated in the United States (39.0%) and Japan (14.6%), and primarily used cohort designs (80.5%), followed by cross-sectional designs (12.2%). The mean sample size was 617.14 (standard deviation = 1,401.37), with most studies primarily including multiple tumor types (31.7%) or breast cancer survivors (26.8%). Machine learning algorithms (43.9%) was the most used AI method, followed by natural language processing (29.3%), AI-driven chatbots (17.1%), and decision support tools (9.8%). The most common inputs to the AI algorithms were textual data, patient-reported symptoms, and physiologic measurements. The most examined symptom was pain (34.2% of studies), followed by fatigue and nausea (17.1% of studies each). Overall, the review showed increasing AI technology use in the prediction and monitoring of cancer symptoms. CONCLUSION AI is being used to enhance symptom monitoring in various cancer settings. When considering integration into clinical practice, standardization of data capture, the use of analytics, investing in infrastructure, and the end-user experience should be considered for successful implementation and monitoring the improvement of patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Science Centre, Toronto, ON, Canada.
- Human Performance Research Centre, INSIGHT Research Institute, University of Technology Sydney (UTS), Sydney, NSW, Australia.
- School of Nursing and Midwifery, La Trobe University, Melbourne, VIC, Australia.
- School of Nursing and Midwifery, Edith Cowan University, Perth, WA, Australia.
- Elzaitoun Specialized Hospital, Ministry of Health and Population, Amreya, Egypt.
- Mount Sinai Medical Center, Miami, FL.
ORCID-Profile: Sanam Tabataba Vakili, Darren Haywood, Aalaa M Abdou, Chia Jie Tan, Carla Thamm, Rhys Bernard, Elaine P Kuhn, Jennifer Y Y Kwan, Shing Fung Lee, Nicolas H Hart, Amanda Drury, Elwyn Zhang, Fredrick D Ashbury, Grigorios Kotronoulas, Edward Chow, Michael Jefford, Raymond J Chan, Rouhi Fazelzad, Muna Alkhaifi
Zitieren
APA
Tabataba Vakili, S., Haywood, D., Kirk, D., Abdou, A. M., Gopalakrishnan, R., Sadeghi, S., Guedes, H., Tan, C. J., Thamm, C., Bernard, R., Wong, H. C. Y., Kuhn, E. P., Kwan, J. Y. Y., Lee, S. F., Hart, N. H., Paterson, C., Chopra, D. A., Drury, A., Zhang, E., …, & Multinational Association of Supportive Care in Cancer (MASCC) Survivorship Study Group (2024). Application of Artificial Intelligence in Symptom Monitoring in Adult Cancer Survivorship: A Systematic Review. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci.24.00119
Vancouver
Tabataba Vakili S, Haywood D, Kirk D, Abdou AM, Gopalakrishnan R, Sadeghi S, et al. Application of Artificial Intelligence in Symptom Monitoring in Adult Cancer Survivorship: A Systematic Review. JCO Clinical Cancer Informatics. 2024. doi:10.1200/cci.24.00119
BibTeX
@article{TabatabaVakili2024,
author = {Tabataba Vakili, Sanam and Haywood, Darren and Kirk, Deborah and Abdou, Aalaa M and Gopalakrishnan, Ragisha and Sadeghi, Sarina and Guedes, Helena and Tan, Chia Jie and Thamm, Carla and Bernard, Rhys and Wong, Henry C Y and Kuhn, Elaine P and Kwan, Jennifer Y Y and Lee, Shing Fung and Hart, Nicolas H and Paterson, Catherine and Chopra, Deepti A and Drury, Amanda and Zhang, Elwyn and Raeisi Dehkordi, Shayan and Ashbury, Fredrick D and Kotronoulas, Grigorios and Chow, Edward and Jefford, Michael and Chan, Raymond J and Fazelzad, Rouhi and Raman, Srinivas and Alkhaifi, Muna and Multinational Association of Supportive Care in Cancer (MASCC) Survivorship Study Group, Multinational Association of Supportive Care in Cancer (MASCC) Survivorship Study Group},
title = {Application of Artificial Intelligence in Symptom Monitoring in Adult Cancer Survivorship: A Systematic Review},
journal = {JCO Clinical Cancer Informatics},
year = {2024},
number = {8},
doi = {10.1200/cci.24.00119}
}
EUVIMED